H. Kato - Concepedia

Author

H. Kato

The University of Tokyo ORCID

Also Known As

H E Kato, H KATO, H Kato, H Kunitoh, H. KATO, H. Kato, HARUBUMI KATO, HISANORI KATO, Harubumi KATO, Harubumi Kato

478

Publications

8.5K

Citations

H-Index

274

Concepts

All Affiliations

The University of Tokyo Tohoku University Tokyo Medical University Tokyo University of Agriculture International University of Health and Welfare

About

H. Kato is an author at The University of Tokyo specializing in medicine, physiology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	112	4.2K
2	Health Sciences	25	54	1.6K
3	Natural Sciences	13	14	358
4	Engineering	8	8	296
5	Education	2	2	25

H. Kato

196

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. Kiyoyuki Furuse, M. Fukuoka, H. Kato, Journal of Clinical Oncology	1993	283
Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). H. Kato, Teresa N. Faria, Bethel Stannard, Journal of Biological Chemistry Kinase-deficient Igf-i ReceptorsHuman GrowthImmunologyIgf-i ReceptorInsulin Signaling	1993	245
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines Glen J. Weiss, Lynne Bemis, Eri Nakajima, Annals of Oncology Egfr ExpressionOncologyMedicinePathologyCancer Genomics	2008	240
Temporal profile of heat shock protein 70 synthesis in ischemic tolerance induced by preconditioning ischemia in rat hippocampus Y. Liu, H. Kato, Naoki Nakata, Neuroscience Rat HippocampusHyperthermiaNeurophysiologyPhysiologyTemporal Profile	1993	159
Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. H. Kato, Teresa N. Faria, Bethel Stannard, Molecular Endocrinology Insulin ReceptorInsulin SignalingSignaling PathwayIgf-i ActionReceptor Tyrosine Kinase	1994	145
Purification and identification of [hydroxyprolyl3]bradykinin in ascitic fluid from a patient with gastric cancer. Hiroshi Maeda, Yasuhiro Matsumura, H. Kato Journal of Biological Chemistry Tumor BiologyChemoprevention StrategyBiochemistryMedicineBioanalysis	1988	128
Randomized Double-Blind Placebo-Controlled Trial of Bestatin in Patients With Resected Stage I Squamous-Cell Lung Carcinoma Yukito Ichinose, Keiichiro Genka, Teruaki Koike, JNCI Journal of the National Cancer Institute	2003	122
Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases Yuichi Oishi, Zhengwei Fu, Yoshinari OHNUKI, British Journal of Dermatology	2002	115
Regional impairment of protein synthesis following brief cerebral ischemia in the gerbil Tsutomu Araki, H. Kato, Teruyoshi Inoue, Acta Neuropathologica Cerebral Vascular RegulationIschemic StrokeNeurophysiologyMedicinePhysiology	1990	111
Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16 Masato Imae, Zhengwei Fu, Akira Yoshida, Journal of Molecular Endocrinology GeneticsGenomic MechanismMolecular GeneticsInsulin SignalingFoxo Genes	2003	110

Page 1